CYTK - Cytokinetics Inc

$2.64 -0.20 | -7.04%
Today's Range: 2.48 - 2.87
CYTK Avg. Daily Volume: 1,388,355
12/18/09 - 4:00 PM ET
TRADE NOW
Company Profile
Price and Volume
Recent Price 2.84
52 Week High 5.55
52 Week Low 1.39
Avg. Daily Vol. (Mil) 0.57
Beta (3 year) 2.06
Share Related Items
Mkt Cap (Mil) 173.04
Shares Out (Mil) 60.93
Float (Mil) 60.23
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 6.00
Current Ratio 6.30
LT Debt/ Equity 0.01
Total Debt / Equity 0.03
Valuation Ratios
Price Earnings 6.90
Price/Sales 2.07
Price/Book 1.54
Price/Cash Flow 6.10
Per Share Data
Earnings 0.41
Sales 1.37
Book Value 1.84
Cash Flow 0.46
Business Summary
A clinical-stage biopharmaceutical company, which focused on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.
General Information
280 East Grand Avenue
South San Francisc, CA 94080
www.cytokinetics.com
Industry : Drugs
Sector: Health Care
Employees: 110
CEO: Robert I. Blum
Short Interest
Current Month (Mil) 1.60
Previous Month (Mil) 1.41
Short Interest Ratio (Days) 4.50
Management Effectiveness
Return on Equity 23.30
Return on Assets 19.50
Return on Investments 23.10
Profitability
Gross Margin n.a.
EBIT Margin 33.60
Profit Margin 31.30
Latest CYTK Headlines

Brokerage Partners

TheStreet Premium Services

All Services